↓ Skip to main content

A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells

Overview of attention for article published in Molecular Cancer Therapeutics, October 2009
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
4 news outlets
patent
2 patents

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
69 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells
Published in
Molecular Cancer Therapeutics, October 2009
DOI 10.1158/1535-7163.mct-09-0444
Pubmed ID
Authors

Tohru Yamada, Rajeshwari R. Mehta, Fatima Lekmine, Konstantin Christov, Marissa L. King, Dibyen Majumdar, Anne Shilkaitis, Albert Green, Laura Bratescu, Craig W. Beattie, Tapas K. Das Gupta

Mendeley readers

The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
Unknown 68 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 18 26%
Researcher 14 20%
Student > Ph. D. Student 12 17%
Student > Doctoral Student 5 7%
Student > Bachelor 5 7%
Other 8 12%
Unknown 7 10%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 28 41%
Agricultural and Biological Sciences 16 23%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Immunology and Microbiology 3 4%
Medicine and Dentistry 2 3%
Other 9 13%
Unknown 7 10%

Attention Score in Context

This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 May 2022.
All research outputs
#1,032,318
of 21,366,128 outputs
Outputs from Molecular Cancer Therapeutics
#106
of 3,686 outputs
Outputs of similar age
#25,357
of 297,679 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#6
of 50 outputs
Altmetric has tracked 21,366,128 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,686 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 297,679 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.